焦虑作为治疗结果的变量在患有慢性阻燃性咳的个体中的流行
Miranda L Wright1,2, Laurie Slovarp3, Jane Reynolds3
1Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City.
American journal of speech-language pathology
|December 5, 2023
概括
在慢性不耐咳 (CRC) 患者中,焦虑是常见的. 焦虑症患者在行为性咳抑制疗法 (BCST) 中表现出更大的改善,这表明焦虑查可能会改善CRC治疗结果.
科学领域:
- 肺部病理学 肺部病理学
- 精神病学是一个精神病学.
- 临床医学 临床医学
背景情况:
- 焦虑是患有咳的患者常见的并发症.
- 慢性难治性咳 (CRC) 患者中焦虑的患病率在很大程度上是未知的.
- 目前的CRC评估并不经常评估焦虑.
研究的目的:
- 调查CRC患者中潜在的焦虑患病率.
- 探索接受行为性咳抑制疗法 (BCST) 的CRC患者焦虑和治疗结果之间的关联.
主要方法:
- 来自专科诊所的86名CRC患者组成的队列完成了BCST前后的莱斯特咳问卷 (LCQ).
- 根据医疗记录或GAD-7分数,参与者被分为积极焦虑屏幕 (PAS) 和消极焦虑屏幕 (NAS) 组.
- 焦虑查使用电子医疗记录和通用焦虑障碍-7 (GAD-7) 尺度.
主要成果:
- 43%的CRC患者的焦虑查结果呈阳性 (PAS组).
- 89%的PAS患者在BCST后的LCQ得分中报告了临床上有意义的改善,而NAS患者的这一比例为65%.
- 在BCST之后,PAS组在LCQ得分上表现出显著更大的改善 (p = .002,Cohen的d = 0.7).
结论:
- 在被诊断为CRC的患者中,焦虑似乎很普遍.
- 对焦虑呈阳性查的CRC患者可能会从BCST中获得更大的好处.
- 这些发现表明,焦虑评估可能是CRC管理的宝贵组成部分.
相关概念视频
01:18Anxiety: Overview
280
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
280
01:22Behavior Therapy
54
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
54
01:26COPD: Management Using Bronchodilators and Corticosteroids
214
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
214
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:26Anxiolytic Drugs: Overview
325
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
325
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K